| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.014 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |